SEC Filing Details
Document Details
Form
Filing Date
Feb 8, 2024
Document Date
Feb 7, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Aclaris Therapeutics, Inc.
Issuer
Aclaris Therapeutics, Inc.
Filer
LEONARD BRADEN MICHAEL